cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Codexis Inc
13 own
10 watching
Current Price
$2.47
$-0.01
(-0.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
164.74M
52-Week High
52-Week High
13.03
52-Week Low
52-Week Low
2.415
Average Volume
Average Volume
0.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization164.74M
icon52-Week High13.03
icon52-Week Low2.415
iconAverage Volume0.6M
iconDividend Yield--
iconP/E Ratio--
What does the Codexis Inc do?
Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also improves the pharmaceuticals companies manufacturing productivity and efficiency, as well as helps in outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. Further, the company develops biocatalysts for use in the fine chemicals market, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Read More
How much money does Codexis Inc make?
News & Events about Codexis Inc.
Zolmax
1month ago
Codexis, Inc. (NASDAQ:CDXS Get Rating) Director John J. Nicols sold 35,714 shares of the firms stock in a transaction dated Tuesday, April 18th. The stock was sold at an average price of $4.14, for a total transaction of $147,855.96. Following the completion of the transaction, the director now owns...
Simply Wall St
8 months ago
It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...
Ticker Report
9 months ago
Skandinaviska Enskilda Banken AB publ cut its stake in Codexis, Inc. (NASDAQ:CDXS Get Rating) by 23.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,375 shares of the biotechnology ...
Globe Newswire
11 months ago
Collaboration with Merck published in Science magazine REDWOOD CITY, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announces the publication with Merck, known as MSD outside the United ...
Ticker Report
12 months ago
Qube Research Technologies Ltd reduced its position in Codexis, Inc. (NASDAQ:CDXS Get Rating) by 32.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,827 shares of the biotechnology companys stock after selling ...
Frequently Asked Questions
Frequently Asked Questions
What is Codexis Inc share price today?
plus_minus_icon
Can Indians buy Codexis Inc shares?
plus_minus_icon
How can I buy Codexis Inc shares from India?
plus_minus_icon
Can Fractional shares of Codexis Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Codexis Inc stocks?
plus_minus_icon
What is today’s traded volume of Codexis Inc?
plus_minus_icon
What is today’s market capitalisation of Codexis Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Codexis Inc?
plus_minus_icon
What percentage is Codexis Inc down from its 52-Week High?
plus_minus_icon
What percentage is Codexis Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.47
$-0.01
(-0.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$13.35
$-0.50 (-3.61 %)
Vericel Corporation
Vericel Corporation
$33.55
$0.48 (1.45 %)
Mesoblast
Mesoblast
$3.63
$0.18 (5.22 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.32
$0.36 (4.02 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$13.35
$-0.50 (-3.61 %)
Vericel Corporation
Vericel Corporation
$33.55
$0.48 (1.45 %)
Mesoblast
Mesoblast
$3.63
$0.18 (5.22 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.32
$0.36 (4.02 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00